Evaluation of anti-inflammatory and anti-adhesive effects of heparins in human endotoxemia

por Derhaschnig, U, Pernerstorfer, T, Jilma, B
Publicado 2002

P1665: WHOLE-BLOOD ROTATIONAL THROMBOELASTOMETRY (ROTEM) AS A DIAGNOSTIC TOOL IN PATIENTS WITH BLEEDING OF UNKNOWN CAUSE (BUC)

por Mehic, D., Jilma, B., Schörgenhofer, C., Colling, M., Ay, C., Pabinger, I., Gebhart, J.
Publicado 2022

Effect of therapeutic mild hypothermia initiated by cold fluids after cardiac arrest on haemostasis as measured by thrombelastography

por Spiel, A, Kliegel, A, Janata, A, Uray, T, Wandaller, C, Sterz, F, Laggner, A, Jilma, B
Publicado 2008

Dexamethasone inhibits endotoxin‐induced coagulopathy in human lungs

por Bartko, J., Schoergenhofer, C., Schwameis, M., Buchtele, N., Wojta, J., Schabbauer, G., Stiebellehner, L., Jilma, B.
Publicado 2016

Statistical analysis of Goal Attainment Scaling endpoints in randomised trials

por Urach, S, Gaasterland, CMW, Posch, M, Jilma, B, Roes, K, Rosenkranz, G, Van der Lee, JH, Ristl, R
Publicado 2018

Differential in vivo activation of monocyte subsets during low-grade inflammation through experimental endotoxemia in humans

por Thaler, B., Hohensinner, P. J., Krychtiuk, K. A., Matzneller, P., Koller, L., Brekalo, M., Maurer, G., Huber, K., Zeitlinger, M., Jilma, B., Wojta, J., Speidl, W. S.
Publicado 2016

Comparative proteomics reveals unexpected quantitative phosphorylation differences linked to platelet activation state

por Schmidt, G. J., Reumiller, C. M., Ercan, H., Resch, U., Butt, E., Heber, S., Liutkevičiūte, Z., Basílio, J., Schmid, J. A., Assinger, A., Jilma, B., Zellner, M.
Publicado 2019

Myeloid but not epithelial tissue factor exerts protective anti‐inflammatory effects in acid aspiration‐induced acute lung injury

por Kral‐Pointner, J. B., Schrottmaier, W. C., Horvath, V., Datler, H., Hell, L., Ay, C., Niederreiter, B., Jilma, B., Schmid, J. A., Assinger, A., Mackman, N., Knapp, S., Schabbauer, G.
Publicado 2017

P1538: INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): RESULTS FOLLOWING 9-WEEK WASHOUT PERIOD IN PHASE 3 CARDINAL STUDY (NCT03347396)

por Röth, A., Barcellini, W., D’Sa, S., Miyakawa, Y., Broome, C. M., Michel, M., Kuter, D. J., Jilma, B., Tvedt, T. H. A., Weitz, I. C., Sourdille, T., Wang, J., Vagge, D. S., Kralova, K., Shafer, F., Wardecki, M., Lee, M., Berentsen, S.
Publicado 2022

Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19—Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT)

por Karolyi, M., Pawelka, E., Omid, S., Koenig, F., Kauer, V., Rumpf, B., Hoepler, W., Kuran, A., Laferl, H., Seitz, T., Traugott, M., Rathkolb, V., Mueller, M., Abrahamowicz, A., Schoergenhofer, C., Hecking, M., Assinger, A., Wenisch, C., Zeitlinger, M., Jilma, B., Zoufaly, A.
Publicado 2022

Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib

por Kazianka, L, Drucker, C, Skrabs, C, Thomas, W, Melchardt, T, Struve, S, Bergmann, M, Staber, P B, Porpaczy, E, Einberger, C, Heinz, M, Hauswirth, A, Raderer, M, Pabinger, I, Thalhammer, R, Egle, A, Wendtner, C-M, Follows, G, Hoermann, G, Quehenberger, P, Jilma, B, Jaeger, U
Publicado 2017